Alvotech is a biotechnology company that specializes in making biosimilars to create biologic medicines.
Alvotech has raised $165.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2026.
Alvotech's investors include GoldenTree Asset Management, Alvogen, Athos Capital, Shinhan Capital, Baxter Ventures.
Alvotech is headquartered in Reykjavík, Iceland.
Alvotech is a biotechnology company that specializes in making biosimilars to create biologic medicines.
Alvotech is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Alvotech — Funding & Investors." VCBacked, June 15, 2026, https://www.vcbacked.co/company/alvotech. Accessed September 29, 2026.
VCBacked. (2026). Alvotech — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/alvotech
{{cite web |title=Alvotech — Funding & Investors |url=https://www.vcbacked.co/company/alvotech |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated